Transferencia

Guías Clínicas

• Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European Leukemia Net

  Authors: Barbui T, Tefferi A, Vannucchi AM, Passamonti F, Silver RT, Hoffman R, Verstovsek S, Mesa R, Kiladjian JJ, Hehlmann R, Reiter A, Cervantes F, Harrison C, Mc Mullin MF, Hasselbalch HC, Koschmieder S, Marchetti M, Bacigalupo A, Finazzi G, Kroeger N, Griesshammer M, Birgegard G, Barosi G

  Reference: Leukemia. 2018 Feb 27. doi: 10.1038/s41375-018-0077-1

• Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations

  Authors: Marchetti M, Barosi G, Cervantes F, Birgegård G, Griesshammer M, Harrison C, Hehlmann R, Kiladjian JJ, Kröger N, McMullin MF, Passamonti F, Vannucchi A, Barbui T.

  Reference: Leukemia. 2017 Apr;31(4):882-888. doi: 10.1038/leu.2016.283. Epub 2016 Oct 14

• Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

  Authors: Vannucchi AM, Barbui T, Cervantes F, Harrison C, Kiladjian JJ, Kröger N, Thiele J, Buske C; ESMO Guidelines Committee

  Reference: Ann Oncol. 2015 Sep;26 Suppl 5:v85-v99